NuScale Power (SMR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
15 Apr, 2026Executive summary
Annual meeting scheduled for May 29, 2026, at 1:30 p.m. Pacific Time, to be held virtually.
Shareholders can vote online, by phone, mail, or during the virtual meeting.
Proxy materials, including the Notice, Proxy Statement, and Form 10-K, are available online.
Voting matters and shareholder proposals
Election of nine directors is up for shareholder vote.
Advisory vote on executive compensation is included.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Proxies are authorized to vote on other business as may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting FOR all director nominees, executive compensation, and auditor ratification.
Director nominees include Alan L. Boeckmann, Bum-Jin Chung, Shinji Fujino, Stuart Harshaw, John L. Hopkins, Dale Klein, Kent Kresa, Diana J. Walters, and Kimberly O. Warnica.
Latest events from NuScale Power
- Doosan fabrication advanced as Q3 revenue fell to $281K and liquidity reached $1.893B.SMR
Q3 2026 - Q2 revenue fell to $75,000 as $1.9B liquidity supported deployment readiness.SMR
Q2 2026 - Industry-leading SMR technology, robust partnerships, and diverse applications drive growth.SMR
Investor presentation - All proposals passed; management targets positive cash flow and values board diversity.SMR
AGM 2026 - Revenue fell, net loss widened, but liquidity is strong and SMR projects are advancing.SMR
Q1 2026 - Annual meeting to vote on directors, executive pay, auditor, and review governance and compensation.SMR
Proxy filing - $750M raised, $1.3B liquidity, NRC-certified SMR, and $31.5M revenue highlight 2025.SMR
Q4 2025 - Operating losses narrowed and cash position improved as SMR deployment advanced globally.SMR
Q3 2024 - Q1 2025 revenue surged to $13.4M, with narrowed losses and a 20-year ENTRA1 partnership secured.SMR
Q1 2025